EKTA.Y Stock Overview
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Elekta AB (publ) Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr7.57 |
52 Week High | kr8.65 |
52 Week Low | kr6.52 |
Beta | 1.01 |
1 Month Change | 7.53% |
3 Month Change | -6.54% |
1 Year Change | 0.98% |
3 Year Change | -41.50% |
5 Year Change | -37.23% |
Change since IPO | 209.45% |
Recent News & Updates
Recent updates
Shareholder Returns
EKTA.Y | US Medical Equipment | US Market | |
---|---|---|---|
7D | 1.0% | 2.2% | 0.4% |
1Y | 1.0% | 13.3% | 28.8% |
Return vs Industry: EKTA.Y underperformed the US Medical Equipment industry which returned 12% over the past year.
Return vs Market: EKTA.Y underperformed the US Market which returned 29.5% over the past year.
Price Volatility
EKTA.Y volatility | |
---|---|
EKTA.Y Average Weekly Movement | 3.9% |
Medical Equipment Industry Average Movement | 7.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.9% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EKTA.Y has not had significant price volatility in the past 3 months.
Volatility Over Time: EKTA.Y's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 4,584 | Gustaf Salford | https://elekta.com |
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services. It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care.
Elekta AB (publ) Fundamentals Summary
EKTA.Y fundamental statistics | |
---|---|
Market cap | US$2.91b |
Earnings (TTM) | US$134.93m |
Revenue (TTM) | US$1.72b |
21.5x
P/E Ratio1.7x
P/S RatioIs EKTA.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
EKTA.Y income statement (TTM) | |
---|---|
Revenue | kr18.22b |
Cost of Revenue | kr11.32b |
Gross Profit | kr6.90b |
Other Expenses | kr5.47b |
Earnings | kr1.43b |
Last Reported Earnings
Jan 31, 2024
Next Earnings Date
Jun 05, 2024
Earnings per share (EPS) | 3.75 |
Gross Margin | 37.88% |
Net Profit Margin | 7.86% |
Debt/Equity Ratio | 57.2% |
How did EKTA.Y perform over the long term?
See historical performance and comparison